{"id":"W2331674475","doi":"10.1097/coc.0b013e3182467a13","title":"Phase I Trial of AEG35156 an Antisense Oligonucleotide to XIAP Plus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"Medicine; Gemcitabine; Pancreatic ductal adenocarcinoma; Oncology; Adenocarcinoma; Pancreatic cancer; Internal medicine; Cancer research; XIAP; Chemotherapy; Pancreatic carcinoma; Cancer; Apoptosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006688065,0.001227686,0.001637586,0.0002937409,0.0003237305,0.0005823838,0.0005470273,0.0008685398,0.00234827],"category_scores_gemma":[0.000455842,0.000331327,0.000784309,0.0003257413,0.0005937571,0.0004918989,0.0002857374,0.002152486,0.0004847305],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008391488,"about_ca_system_score_gemma":0.00114332,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007563312,"about_ca_topic_score_gemma":0.002008696,"domain_scores_codex":[0.9998092,0.00007173319,0.00001536783,0.0000394637,0.00002239231,0.00004182461],"domain_scores_gemma":[0.9997297,0.00003901148,0.00004927864,0.00001710567,0.00001474953,0.0001501923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5790254,0.06276997,0.01236304,0.001720567,0.001790655,0.001023889,0.0004950751,0.006482259,0.1591786,0.0004683278,0.004560015,0.1701223],"study_design_scores_gemma":[0.3476886,0.6214088,0.01270218,0.00006422328,0.0004647501,0.0006408987,0.00006992179,0.001710064,0.01157994,0.0001718068,0.003474143,0.00002455431],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954062,0.001557981,0.0002308727,0.000215295,0.00008746066,0.001064321,0.0002432149,0.00005769357,0.001136995],"genre_scores_gemma":[0.9935754,0.001551252,0.001036529,0.0003528774,0.0001112331,0.0009881795,0.0009012642,0.00001306754,0.001470259],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00234827,"threshold_uncertainty_score":0.007855773,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03633009900065996,"score_gpt":0.3926177608916083,"score_spread":0.3562876618909483,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}